These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

876 related articles for article (PubMed ID: 17003063)

  • 1. Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005.
    Finch R; Hunter PA
    J Antimicrob Chemother; 2006 Sep; 58 Suppl 1():i3-i22. PubMed ID: 17003063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovation - drugs and diagnostics.
    Finch R
    J Antimicrob Chemother; 2007 Aug; 60 Suppl 1():i79-82. PubMed ID: 17656390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of development of new antimicrobial drugs: a potential serious threat to public health.
    Norrby SR; Nord CE; Finch R;
    Lancet Infect Dis; 2005 Feb; 5(2):115-9. PubMed ID: 15680781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerating resistance, inadequate antibacterial drug pipelines and international responses.
    Theuretzbacher U
    Int J Antimicrob Agents; 2012 Apr; 39(4):295-9. PubMed ID: 22341298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.
    Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H
    Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial resistance--the clinical challenge.
    Finch R
    Clin Microbiol Infect; 2002; 8 Suppl 3():21-32; discussion 33-5. PubMed ID: 12519346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What if there were no new antibiotics? A look at alternatives.
    Rello J; Bunsow E; Perez A
    Expert Rev Clin Pharmacol; 2016 Dec; 9(12):1547-1555. PubMed ID: 27678160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing antimicrobial resistance through appropriate antibiotic usage in Singapore.
    Hsu LY; Kwa AL; Lye DC; Chlebicki MP; Tan TY; Ling ML; Wong SY; Goh LG
    Singapore Med J; 2008 Oct; 49(10):749-55. PubMed ID: 18946605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ; Bradford PA
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The millennium bugs--the need for and development of new antibacterials.
    Bax R; Mullan N; Verhoef J
    Int J Antimicrob Agents; 2000 Sep; 16(1):51-9. PubMed ID: 11185414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective antibacterials: at what cost? The economics of antibacterial resistance and its control.
    White AR;
    J Antimicrob Chemother; 2011 Sep; 66(9):1948-53. PubMed ID: 21700625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report from the European Conference on the Role of Research in Combating Antibiotic Resistance, 2003.
    Cornaglia G; Lönnroth A; Struelens M
    Clin Microbiol Infect; 2004 May; 10(5):473-97. PubMed ID: 15113331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of antibacterials in children: a report of the Specialist Advisory Committee on Antimicrobial Resistance (SACAR) Paediatric Subgroup.
    Sharland M;
    J Antimicrob Chemother; 2007 Aug; 60 Suppl 1():i15-26. PubMed ID: 17656377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relentless rise of resistance?
    Wise R
    J Antimicrob Chemother; 2004 Aug; 54(2):306-10. PubMed ID: 15231764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of vaccines on antimicrobial resistance.
    Buchy P; Ascioglu S; Buisson Y; Datta S; Nissen M; Tambyah PA; Vong S
    Int J Infect Dis; 2020 Jan; 90():188-196. PubMed ID: 31622674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global geographic trends in antimicrobial resistance: the role of international travel.
    Frost I; Van Boeckel TP; Pires J; Craig J; Laxminarayan R
    J Travel Med; 2019 Dec; 26(8):. PubMed ID: 31115466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial agents are societal drugs: how should this influence prescribing?
    Sarkar P; Gould IM
    Drugs; 2006; 66(7):893-901. PubMed ID: 16740004
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 44.